J B Chemicals & Pharmaceuticals Ltd.

J. B. Chemicals & Pharmaceuticals Ltd. (JBCPL), known to many as Unique Pharmaceutical Laboratories is one of India’s leading global pharmaceutical companies. The company manufactures and markets a wide range of pharmaceutical formulations, herbal remedies, bulk drugs, intermediates and radio-diagnostics.

more..

name :
email :

BSE | NSE



JBCPL announces impressive Q1 results Unaudited Financial Results for the quarter ended 30th June, 2008 CHAIRMAN'S SPEECH 2008 SHAREHOLDING PATTERN AS ON 30/06/2008 Outcome of Board Meeting dated 4th July, 2008 Annual Report 07-08 Update on Buyback dated 28/05/2008 (Filing exemption application with SEBI) Audited Financial Results for FY 2007-08. - Recommends 25% Dividend AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH, 2008 JBCPL announces impressive Q1 results Unaudited Financial Results for the quarter ended 30th June, 2008 CHAIRMAN'S SPEECH 2008 SHAREHOLDING PATTERN AS ON 30/06/2008 Outcome of Board Meeting dated 4th July, 2008 Update on Buyback dated 28/05/2008 (Filing exemption application with SEBI). Audited Financial Results for FY 2007-08. - Recommends 25% Dividend. AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH, 2008 Board approves Share Buyback at a maximum price of Rs. 70/- per share - April 2008. Un-audited Results - December 2007. SHAREHOLDING PATTERN AS ON 31/12/2007 UNAUDITED FINANCIAL RESULTS for the 2nd QTR ended 30th SEPTEMBER,2007 UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH SEPTEMBER, 2007 Chairman’s Speech - AGM 2007. SHAREHOLDING PATTERN AS ON 30/06/2007 Annual Report 2006-07 AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH, 2007 J. B. Chemicals & Pharmaceuticals Limited Announces Audited Financial Results for FY 2006-07. Turnover Up 14% Total Dividend 130% - Recommends 75% Final Dividend. SHAREHOLDING PATTERN AS ON 31/03/2007 Unaudited Financial Results for the Third Quarter ended 31st December 2006 J B Chemicals Plans to Invest in Gujarat to set up a Pharma SEZ Signs a Memorandum of Understanding with the Government of Gujarat for a Pharma SEZ at Panoli, Gujarat J.B. Chemicals makes Strategic Investment of USD 5.1 Mn. in Biotech Laboratories (Pty) Ltd., South Africa J.B. Chemicals Announces Q2 Results -September 2006 J.B. Chemicals & Pharmaceuticals Ltd. Announces a Licensing Agreement with Gilead Sciences Inc. for Manufacturing and Distribution of a Generic Version of an Anti-Viral Patented drug in 95 countries J. B. CHEMICALS reports increase in Net Sales and PAT for Q1 ended June 30, 2006. US FDA ACCEPTS JBCPL’s ELECTRONIC USDMF FILING FOR DICLOFENAC DIETHYLAMINE J. B. Chemicals announces encouraging Q3 results. Chairman’s Speech
more news..